What is I3LUNG
I3LUNG is a European project funded under the framework of the H2020 call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.
For patients
“We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry.„
Find out the most relevant news on the latest advancements in lung cancer!
News
August, 5 2022
After the summary done for the first day of the kick-off, let’s dive into the second and last day of […]
News
August, 4 2022
As mentioned in our previous article, the kick-off meeting on July 1-2 officially started the EU I3LUNG Project. Let’s dive […]
News
August, 3 2022
I3LUNG is a collaborative, 5-year, 10M€ EU-funded project aiming to create an artificial intelligence (AI)-based personalized decision-making tool to aid both […]